September looms as a risk month for stocks, Yardeni says
This article summarizes the top insider buys and sells reported on Tuesday, July 1, 2025, for US stocks.
Top Insider Buys:
Kymera Therapeutics Inc (NASDAQ:KYMR): A group of directors, including Mark N Lampert, collectively purchased $13.9 million worth of Kymera Therapeutics Inc stock on June 30, 2025. The purchases were made at $44 per share, near the current trading level of $44.44. The insider buying comes as the stock shows strong momentum, with a 43.6% return over the past year. The transactions involved the acquisition of common stock by Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., and Biotechnology Value Trading Fund OS LP.
BEXIL INVESTMENT TRUST (BXSY): Winmill & Co, an affiliate of the registered investment adviser of BEXIL INVESTMENT TRUST, reported purchasing a total of 2,675 shares in two transactions, valued at $35,636. The purchases occurred on June 30 and July 1, 2025, with prices ranging from $13.31 to $13.38 per share.
Texas Pacific Land Corp (NYSE:TPL): Horizon Kinetics Asset Management LLC, a ten percent owner of Texas Pacific Land Corp, reported purchasing 1 share of the company’s common stock at $1053.06 on June 30, 2025. Following this transaction, Horizon Kinetics Asset Management LLC directly owns 1,166,253 shares of Texas Pacific Land Corp.
Hurco Companies Inc (NASDAQ:HURC): Michael Doar, Executive Chairman of Hurco Companies Inc, recently purchased 2,000 shares of the company’s common stock at $18.50, in a transaction valued at $37,000. The transaction occurred on June 27, 2025, and following the purchase, Doar directly owns 223,460 shares of Hurco Companies.
RYVYL Inc (NASDAQ:RVYL): S8 Global Fintech & Regtech Fund, a ten-percent owner of RYVYL Inc, recently purchased 114,491 shares of the company’s common stock for a total of $91,049. The transactions occurred on June 27 and June 30, 2025, at prices of $0.7946 and $0.7998 per share, respectively.
Top Insider Sells:
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS): OrbiMed Advisors LLC, a major shareholder in Corvus Pharmaceuticals, Inc., sold 1,176,332 shares of common stock on June 27, 2025, for approximately $4.89 million. The shares were sold at a price of $4.1586.
Karat Packaging Inc (NASDAQ:KRT): Alan Yu, Chief Executive Officer of Karat Packaging Inc, sold 112,500 shares of common stock on June 27, 2025, at a price of $27.00, in a transaction amounting to $3,037,500.
BridgeBio Pharma, Inc. (NASDAQ:BBIO): Viking Global Investors LP, a ten percent owner of BridgeBio Pharma, Inc., sold 3,500,000 shares of common stock on June 27, 2025, at a price of $44, totaling approximately $154 million.
NVIDIA Corp (NASDAQ:NVDA): President and CEO Jen Hsun Huang sold 217,910 shares of common stock on June 27th, June 30th, and July 1st, at prices ranging from $152.2292 to $158.4551, resulting in a total value of $35,161,723.
Micron Technology (NASDAQ:MU): Executive Vice President and Chief Business Officer Sumit Sadana sold 92,638 shares of common stock on June 27, 2025, at a weighted average price of $125.49, for a total transaction value of $11,625,142.
Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company’s prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer clues about management’s confidence in the company’s future performance or potential concerns. However, it’s important to consider these transactions in the context of broader market trends, company fundamentals, and individual investment goals.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.